Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm

NCT05027997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharospasm
Dystonia

Interventions

DRUG: Dipraglurant
DRUG: Placebo

Sponsor

Addex Pharma S.A.